SHANGHAI, Oct. 15 /PRNewswire-Asia/ -- Sundia MediTech, a leading pharmaceutical R&D outsourcing service company inChina, announced today that Mr. Charles D. Maher has been appointed Senior Vice President of Sales and Marketing of Sundia.
Prior to joining Sundia, Mr. Maher was Executive Vice
Mr. Maher has extensive experience in leading many aspects of CRO industry operations, and has accumulated a consistent track record of improving bottom line by growing revenue, reducing costs and maximizing employee productivity through his career.
In his new role in Sundia, Mr. Maher will be responsible for Sundia's business development in global market. Mr. Maher will report directly to Dr. Xiaochuan Wang, Chairman and CEO of Sundia.
"Mr. Maher's past experience is a perfect match to Sundia's business needs. I am very pleased to welcome him to join our team at this very important point of Sundia's development," commented Dr. Xiaochuan Wang. "With the rapid growth of Sundia, we need more experienced and high quality leaders in the company. I have full confidence that our business development team will deliver a outstanding result under the leadership of Mr. Maher."
Mr. Maher had his college education in Miami University with a double major in marketing management and chemistry, and obtained his MBA degree from Ohio State University in USA.
About Sundia MediTech
Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) based in Shanghai, China. It was founded in Shanghai in 2004 by a group of U.S. pharmaceutical industry veterans to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide.
SOURCE Sundia MediTech Company
Subscribe to our Free Newsletters!
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...
Video-electroencephalography monitoring is a diagnostic technique that records the electrical ...
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...View All